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5-HTTLPR polymorphisms mediate different levels of inhibitory control.
More impulsive behavior in healthy carriers of the low expressive genotype.
These initial observations will allow extensions to patient populations.
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a b s t r a c t
Serotoninergic transmission is reliably implicated in inhibitory control processes. The aim of this study
was to test the hypothesis if serotonin transporter polymorphisms mediate inhibitory control in healthy
people. 141 healthy subjects, carefully screened for previous and current psychopathology, were geno-
typed for the 5-HTTLPR and rs25531 polymorphisms. Inhibitory control was ascertained with the Stopvailable online 17 October 2014
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Signal Task (SST) fromtheCambridgeNeuropsychological TestAutomatedBattery (CANTAB). The triallelic
gene model, reclassiﬁed and presented in a biallelic functional model, revealed a dose-dependent gene
effect on SST performance with Individuals carrying the low expressive allele had inferior inhibitory con-
trol compared to high expressive carriers. This directly implicates serotonin transporter polymorphisms
(5-HTTLPR plus rs25531) in response inhibition in healthy subjects.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC. Introduction
Impulsivity can be understood as arising from impairment in
nhibitory control [1]. Impaired serotonin (5-HT) function [2] has
een shown to contribute to the neurobiology of impaired execu-
ive control processes [3] and impulsivebehaviors [4].However, the
enetic contribution of these behavioral processes is incompletely
nderstood.
The 5-HT-transporter-linked polymorphic region (5-HTTLPR) in
he promoter region of the human 5-HT transporter (5-HTT) gene
SLC6A4) results in twomainalleles or variants [5]; the short (S) and
ong (L), comprising 14 and 16 copies of a 20–23 nucleotide repeat
∗ Corresponding author at:Department of Psychology, University ofOslo, Norway.
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cassettes, respectively. A functional triallelic 5-HTTLPR polymor-
phism include an additional single nucleotide polymorphism A>G
SNP (rs25531) in theﬁrst of two22-bp imperfect repeats thatdeﬁne
the 16-repeat L allele. The 5-HTTLPR L allele combined with the
major allele A in rs25531 (LA) is associated with higher expression
of the transporter protein compared to the LG allele and the short
S allele [6], resulting in altered 5-HT tone and neurotransmission.
Few studies have directly studied the potential role of the
5-HTTLPR polymorphisms and inhibitory control in healthy sub-
jects under laboratory conditions and results so far are conﬂicting.
Whereas some studies found no association between 5-HTTLPR
variants and measures of inhibitory control and impulsivity [7,8],
others reported that the short allele of the 5-HTTLPR may medi-
ate impairments in impulse control [9,10]. Operationalization of
inhibitory control varies across studies, with three of the four stud-
ies using variants of continuous performance/go-no go tasks, and
another study applying the Stop Signal Task [8], which requires
en access article under the CC BY-NC-ND license (http://creativecommons.
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he cancelation of a motor response that has already been ini-
iated [11]. The Stop Signal Task offers signiﬁcant psychometric
dvantages over conventional Continuous Performance, or Go/No
o Task, since the difﬁculty of stopping can be adjusted for each
ndividual by manipulating the delay between the Go stimulus and
he stop signal.
The aim of this study was to test the potential role of the 5-
TTLPR polymorphism in mediating inhibitory control in healthy
eople, speciﬁcally if carriers of the low expressive 5-HT trans-
orter variant (5-HTTLPR S and LG) exhibit less effective inhibitory
ontrol relative to carriers of the high expressive variant (LA).
. Methods
157 healthy subjects (105 females, 52 males) were recruited
rom the general public using advertisements in a local newspa-
er in Oslo. Mean age of the cohort was 36.4 years (SD=13.1),
anging from 19 to 64 years of age. After giving written informed
onsent, the participants provided information about their medical
tatus and underwent psychiatric evaluation including the Diag-
ostic Interview for Genetic Studies [12], the Structural Clinical
nterview for DSM-IV, Axis I and II disorders (SCID I and SCID II).
epression and anxiety symptoms were assessed using the Beck
epression Inventory [13] and the Beck Anxiety Inventory [14],
espectively. The SCID interviews were administered and recorded
y trained clinicians and were subjected to consensus diagnoses.
ubjects fulﬁlling the criteria of any psychiatric diagnosis were
xcluded, including subjects with current/ongoing drug abuse or
ependency. Other exclusion criteria were head trauma during
he last year with loss of consciousness greater than 30min as
ell as other neurological disorders. Education level was classiﬁed
y means of the International Standard Classiﬁcation of Educa-
ion [15]. General cognitive functioning was estimated from scaled
cores of two subtests from the WAIS-III, Picture Completion and
imilarities [16]. The subjects were given a $ 50 gift certiﬁcate for
heir participation. The Regional Ethics Committee approved the
roject.
.1. Genotyping
The biallelic 5-HTTLPR polymorphism, located in the regula-
ory region of the 5-HT transporter gene (SLC6A4), was genotyped
ssentially as described in detail elsewhere [17,18]. A real-time ﬂu-
rescence Light Cycler instrument was used to amplify genomic
NA by polymerase chain reaction (PCR) in a ﬁnal volume of 20L
sing Light Cycler Faststart DNA SYBR Green kit (Roche cat no.
2239264001) with speciﬁc primers (0.5M) [17] generating a
ong (L) 419 base pair (bp) or a short (S) 375bp PCR product. Differ-
nces in product length depend on the variable number of a 22bp
andem repeat (VNTR) sequence in the promoter region. Cycle con-
itions were initiated by 10min denaturation (95 ◦C) followed by
5 cycles at 95 ◦C (10 s), 66 ◦C (10 s) and 72 ◦C (10 s). For the detec-
ion of the additional A>G SNP (rs25531), the PCR fragments were
igested with 1U MspI restriction enzyme (New England Biolabs,
everly, Massachusetts) for 2h at 37 ◦C. The PCR fragments contain
wo obligatory MspI sites, whereas the A>G substitution creates
n additional MspI site. The PCR reaction followed by restriction
igestion and gel electrophoreses provides classiﬁcation of the S,
A and LG alleles.
.2. Inhibitory control measure (the Stop Signal Task; SST)The Stop Signal Task was selected from the Cambridge Neu-
opsychological Test Automated Battery [19]. Trained research
ssistants administered the SST. This task measures the ability toetters 584 (2015) 109–112
inhibit an already-initiated motor response [11]. In a subset of tri-
als (i.e. 25%), an auditory beep occurs (the “stop signal”) to indicate
that the response should be withheld on that particular trial. A pro-
cedure is applied to track the participants’ performance, by varying
the stop signal delay (SSD) parameter after successful and unsuc-
cessful stop attempts. Over time, this tracking procedure stabilizes
the probability of successful inhibition around 0.5 for each subject.
The Stop signal reaction time (SSRT), calculated by subtracting the
SSD50 from the median Go RT, is the main outcome variable. Thus,
the SSRT reﬂects the effectiveness in the ability to inhibit a prepo-
tent response. The total number of Go discrimination errors (i.e. a
right button press to a left-facing arrow) was also registered.
Sixteen subjects failed to achieve convergence, either through
too high (≤60%) or too low (≤40%) levels of successful inhibition.
These staircase failures may arise through strategic slowing of the
go reaction time, or through inconsistent performance or excessive
distraction. They invalidate an assumption of the horse race model
that Go-and stop-related processes are independent [11]. Thus, the
ﬁnal group for analysis was a total of 141 participants (94 females,
47 males).
3. Statistical analyses
One-way ANOVAs were conducted to explore possible group
differences in age, education level (ISCED) and general cognitive
functioning (sub-tests Similarities and Picture Completion from
WAIS-III), as well as symptoms related to depression (BDI) and
anxiety (BAI). Aone-wayANOVAwas conducted topredict StopSig-
nal Task performance from 5-HTTLPR genotype combined with the
A>G SNP (rs25531). Polynomial contrastwas performed to test the
dose effects across genotypes. Levene’s test of homogeneity con-
ﬁrmed that the groups were not signiﬁcantly different in variance,
thus validating use of the F test. Finally, a linear regression model
was conducted to explore the amount of unique variance explained
by genotype after taking variance explained by group differences
(from the ANOVAs) into account.
4. Results
The triallelic classiﬁcation was reclassiﬁed into a functional
model, based on the 5-HTTLPR-directed level of transcriptional
activity of the transporter gene as follows: LG/S, LG/LG and S/S geno-
types were classiﬁed as SS’ (low leveled RNA transcription); LA/S
and LA/LG genotypes were classiﬁed as LS’ (intermediate leveled);
and LA/LA genotype was classiﬁed as LL’ (high leveled) [20].
ThegenotypedistributionwasLALA 22.9%, LGLA 10.2%, LAS39.5%,
LGLG 0.6%, SLG 7.6% and SS 19.1%. The genotype distribution was in
Hardy-Weinberg equilibrium (x2 =0, df=1; p=0.99). The genotype
distribution after exclusion (n=141)was LALA 24.1%, LGLA 9.9%, LAS
41.1%, LGLG 0.7%, SLG 7.8% and SS 16.3%.
There was a signiﬁcant difference between the genotype groups
in education level (F(2, 138) =4.168, p=0.017, 2 =0.057) and a
trending toward signiﬁcant difference in age (F(2, 138) =3.006,
p=0.053, 2 =0.042). There were no statistically signiﬁcant dif-
ferences between 5-HTTLPR sub-groups on BDI, BAI, or the two
subtests from WAIS. Education level and age was therefore added
in the ﬁnal regression model. There was no statistical signiﬁcant
sex by genotype interactions for any of the SST variables. Because
of this, the analyses were collapsed across gender.
Therewas a statistically signiﬁcant effect of 5-HTTLPR plus A>G
SNP on the SSRT variable (F(2, 138) =3.518, p=0.032, 2 =0.049).
Polynomial contrast measure revealed a linear effect of the num-
ber of low expressive alleles (CE=21.6, p=0.009) (Fig. 1). SSRT
was predicted by 5-HTTLPR genotype (Beta =0.195, p=0.022), but
not by age (Beta =0.157, p=0.65) or education level (Beta =−0.030,
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lleles: LL’ (high leveled RNA transcription), LS’ (intermedium leveled) and SS’ (low
eveled). Error bars =95% CI.
= 0.724). The overall model explained about seven percent of the
otal variance (R2 =0.072).
There were no statistically signiﬁcant differences across the
enotype groups on Go Reaction Time (F(2, 138)) = 0.969, p=0.382)
nd number of Go Discrimination Errors (F(2, 138) =0.178),
= 0.837). The Go Reaction Times (means and standard deviations)
or the three genotype groups were: LL: 404.0 (93.2), LS: 390.6
80.2), SS: 396.9 (96.2). Number of Go Discrimination Errors were:
L: 4.5 (5.8), LS: 5.3 (6.3), SS: 6.4 (7.0).
There were no signiﬁcant differences between the genotype
roups on Go reaction time or Go Errors, or any SST measure
ased on the original biallelic gene model (ignoring the A>G
s25531SNP).
. Discussion
The main ﬁnding was that 5-HTTLPR polymorphisms predict
esponse inhibition in healthy subjects. Healthy subjects carrying
he high expressive allele exhibited signiﬁcantly faster inhibition of
prepotent response as compared to the low expressive genotype.
his suggestsmore impulsivebehavior in carriersof the lowexpres-
ive genotype. There were no differences between the groups with
espect to the basic Go reaction time or number of Go Discrim-
nation Errors, indicating that the genotype effect on response
nhibition does not reﬂect general cognitive slowing or deﬁcit in
asic discrimination ability. Furthermore, the association between
he 5-HT transporter and the speciﬁc ability to inhibit a prepotent
esponse was observed in the context of no differences between
he genotype subgroups on indicators of general cognitive abilities
r in self-reported depressivemood or anxiety symptoms (Table 1).
Both the biallelic- and triallelic 5-HTTLPR model are often
ichotomized in dominant gene models, i.e. carriers of the
able 1
emographic, psychometric and clinical data for genotype sub-groups. Values rep-
esent mean and standard deviation. The p-values refer to the results from one-way
NOVAs.
LL (n=34) LS (n=72) SS (n=35) p Value
Age 32.4 (11.7) 34.0 (12.0) 39.2 (13.5) 0.053
Education level (ISCED) 4.7 (0.7) 4.6 (0.8) 5.1 (0.9) 0.017
Similarities (scaled) 11.3 (2.6) 11.4 (3.4) 11.5 (3.0) 0.990
Picture completion (scaled) 13.1 (2.8) 13.5 (3.3) 12.5 (3.3) 0.305
Beck depression inventory 2.6 (2.3) 3.2 (5.0) 4.1 (6.0) 0.418
Beck anxiety inventory 2.3 (2.3) 2.5 (3.4) 2.1 (2.2) 0.768etters 584 (2015) 109–112 111
heterozygous LS variant are pooled with the homozygous SS vari-
ants However, the rationale for dichotomizing genotypes in a
recessive-dominant model based on the triallelic functional gene
model, suggested by Hu and collegues [6], is not well founded, as
no ﬁrm conclusions can be drawn about the functional proper-
ties of the triallelic gene model [21–24]. Several studies support
a functional dominant – recessive effect for the biallelic gene
model but these ﬁndings have also been inconclusive [21,25–28].
Therefore, our data add important novel information suggesting a
dose-dependent effect for the 5-HTTLPR variants on impulsivity.
Our results are in line with work showing that healthy carriers
of the long 5-HTTLPR allele exhibit signiﬁcantly better performance
on measures of impulsivity as compared to short allele carriers
[9,10]. Short allele carriers also showed impaired post error and
post-conﬂict behavioral adjustment, as compared to long allele
carriers, on a modiﬁed ﬂanker task [29]. 5-HT inﬂuences affec-
tive decision making [30] and three studies reported reduced Iowa
Gambling Task performance among short allele 5-HTTLPR carriers
[31–33]. There are, however, studies including other executive con-
trol tasks reporting opposite results. Three studies, none taking the
triallelic model into consideration, found that short allele carriers
outperformed their long allele counterparts. Strobel and collegues
[34] found that SS and LS variants showed higher efﬁciency of cog-
nitive control processes compared to LL allele carriers. Borg and
collegues [35] applied the Wisconsin Card Sorting Test (WCST) and
found that short allele carriers had fewer perseverative errors and
they needed fewer cards to complete the task. Although typically
described as a set shifting task, WCST is complex and the authors
state that their study does not resolvewhich of all component parts
of WCST performance the 5-HTTLPR inﬂuences. In a recent study
on working memory, also in healthy subjects, it was found that
short allele carriers performedbetter than longallele carriers.How-
ever, this was a change detection task reﬂecting primarily storage
capacity in working memory and not really cognitive control [36].
Although there are exceptions,most studies reporting less effec-
tive cognitive control in short allele as compared to long allele
5-HTTLPR carriers have taken the triallelic model into consider-
ation. Studies reporting no gene effects or the opposite pattern, i.e.
better performance on cognitive control tasks in short versus long
allele carriers, have in most cases based the analyses on the bial-
lelic model. It seems unlikely that a variation with respect to gene
model is the only explanation for discrepant ﬁndings when link-
ing 5-HTTLPR and cognitive control. An intriguing idea, and which
may be relevant in this context, is that the 5-HTTLPR short allele
in general increases sensitivity to the environment, indicating that
this gene variant may not be a vulnerability genotype as much as
a plasticity genotype [37–39]. Increased neural plasticity or behav-
ioral malleability might implicate that carriers with the short allele
polymorphismwill beneﬁtmore than long allele carriers from tasks
with systematic feedback. Thus, this might be a possible explana-
tion for the reported ﬁnding of better Wisconsin Card Sorting Test
performance in short allele carriers, where the subject receives
continuous feedback [35]. In our study, based on the Stop Signal
Task, the subjects receive no such feedback. Similarly, in the Iowa
Gambling Task there is no contingency with respect to what is the
“correct” response.
These initial observations will allow extensions to patient
populations. Understanding how genetic variation within key
transmitter systems contribute to functional component of the
phenotypic expression of substance use [40] and mood and anxiety
disorders [41]may provide insight intomechanisms thatmay drive
the development, maintenance, and treatment of these disorders.Animalmodels are alsomakingan increasing contribution toour
understanding of response inhibition and impulsivity and should
be integrated with human studies in the future. A study that used
Stop Signal Task behavioral paradigm in mouse has shown that
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. Conclusions
Healthy individuals carrying the low expressive 5-HT trans-
orter polymorphisms (5-HTTLPR plus rs25531) exhibit less ability
o inhibit a prepotent response as compared to high expressive
arriers. This suggests a direct role of the low expressive 5-HT
ransporter polymorphism in regulating impulsive behavior traits
n healthy people.
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